CN Patent

CN103083672B — 与其它抗糖尿病药组合的dpp-iv抑制剂、包含此类制剂的片剂，和其用途和制备方法

Assigned to Boehringer Ingelheim International GmbH · Expires 2016-09-07 · 10y expired

What this patent protects

本发明涉及药物组合物，其包含DPP‑4抑制剂药物与组合药物的固定剂量组合，其制备方法，及其治疗某些疾病的用途。

USPTO Abstract

本发明涉及药物组合物，其包含DPP‑4抑制剂药物与组合药物的固定剂量组合，其制备方法，及其治疗某些疾病的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN103083672B
Jurisdiction
CN
Classification
—
Expires
2016-09-07
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.